patients with leg ulcers. Previous AVF recommendations
agreed with this statement.370
A recent meta-analysis of SEPS by Luebke and Brunkwall32 reviewed data of studies published between 1985
and 2008 and concluded that SEPS, used as part of a
treatment regimen for severe CVI, benefits most patients in
the short-term regarding ulcer healing and the prevention
of ulcer recurrence. SEPS is safe